Contact Takeda Investor Relations | Takeda Pharmaceuticals
Sign up for our investors newsletter
Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planetSign up
Frequently Asked Questions
You may contact a licensed stockbroker or go through any registered broker-dealer to purchase shares of Takeda.
Takeda’s common shares are traded on the Tokyo Stock Exchange using stock code “4502.” Our ADSs are traded on the New York Stock Exchange using the symbol “TAK”.
An American Depositary Receipt (ADR) is a certificate representing ownership of American Depositary Shares (ADSs) in a non-U.S. corporation. They include the right to attend and vote at AGMs, the receipt of dividends, and other common shareholder rights. One ADS represents 0.5 shares of Takeda’s common stock.
Takeda’s dividend payments have historically been issued on a semi-annual basis in June and December. The record date for year-end dividends is March 31 of each year. The record date for interim dividends is September 30 of each year.
Takeda’s official reporting currency is the yen.
Takeda follows the International Financial Reporting Standards, or IFRS, for its financial reporting.